UK FIRM AIDS PHARMANOVA

BY LUCY PHIRI

BRITISH High Commissioner Nicholas Woolley has observed that Zambia has continued to face alarming rates of undernutrition and that improving nutritional outcomes in the country has long been a priority for the United Kingdom government. 

This content is locked

This is exclusive material. To read full story, click on register and choose one of the premium subscriptions to view this content. Login if you are already a premium user.


New data on COVID-19 vaccine response and clinical outcomes in patients with impaired immune systems

Researchers and clinicians from the University of Sheffield and Sheffield Teaching Hospitals NHS Foundation Trust are part of the ongoing OCTAVE (Observational Cohort Trial-T-cells Antibodies and Vaccine Efficacy in SARS-CoV-2) trial, which is led by the Universities of Glasgow, Birmingham and Oxford and a consortium of leading UK institutions.

Fecal transplants show promise in improving melanoma treatment

In a world-first clinical trial published in the journal Nature Medicine, a multi-center study from Lawson Health Research Institute, the Centre hospitalier de l’Université de Montréal (CHUM) and the Jewish General Hospital (JGH) has found fecal microbiota transplants (FMT) from healthy donors are safe and show promise in improving response to immunotherapy in patients with advanced melanoma.

Pregnant women can contribute to malaria surveillance in sub-Saharan Africa

P. falciparum infection rates in pregnant women attending their first antenatal care visit can be used to estimate the burden of malaria in children living in the community, according to a study led by the Barcelona Institute of Health (ISGlobal) and the Centre for Health Research in Manhica (CISM). The study, published in Nature Communications, confirms that pregnant women are an optimal population to monitor changes in infection prevalence and to adapt control measures.